NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
Key Data Readouts on Track for All Programs in 2024
Randomized Phase 2 Study of 182 Second-Line Colorectal Cancer Patients Fully Enrolled
Key Data Readouts on Track for All Programs in 2024
Randomized Phase 2 Study of 182 Second-Line Colorectal Cancer Patients Fully Enrolled
NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.